#69 Another Needle-Free Epi Option?: An Update on Nasdepi

Send us Fan MailIn this episode, I'm joined by Scott Lyman, CEO and Co-Founder of Belhaven BioPharma, to discuss Nasdepi®, an investigational dry powder epinephrine nasal spray currently in development for the treatment of anaphylaxis.Nasdepi® is designed as a needle-free alternative to traditional auto-injectors, with early clinical data suggesting rapid absorption and strong temperature stability.We talk about:Why alternative delivery systems matterNeedle fears and other real-world barriers to carrying epinephrineHuman factor studies and ease of use in high-stress situationsWhat “investigational” means and where the product stands in developmentThis episode is part of a broader series exploring epinephrine options beginning with episode 67. As always, this podcast does not promote any specific product, just information and education. Episode links:-Nasdepi: https://belhavenbio.com/nasdepi-progress/Special thanks to Kyle Dine for permission to use his song The Doghouse for the podcast theme!www.kyledine.comFind Dr. Whitehouse:-thefoodallergypsychologist.com-Instagram: @thefoodallergypsychologist-Facebook: Dr. Amanda Whitehouse, Food Allergy Anxiety [email protected]